Conversely, in multiple solid tumors, including breast, gastric, and ovarian cancers, elevated PAI-1 expression within tumor tissues is frequently correlated with poor clinical prognosis [46], and circulating PAI-1 levels are regarded as potential prognostic biomarkers in patients with malignancies such as breast cancer [70]. The gene discussed is SERPINE1; the disease is ovarian cancer.